Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences
MJH Life Sciences

SUBSCRIBE: Print / eNewsletter

ASCO 2016 Gynecologic Cancers

Molecular-Based Classification for Endometrial Cancer Could Help Predict Survival

June 23, 2016
  • Leah Lawrence

Researchers were able to molecularly classify endometrial cancers with distinct survival differences using a new classification tool called ProMisE that uses clinically applicable methods.

  • READ >>
  • Add new comment

Cisplatin/Paclitaxel Plus RT Offers Good Results in Advanced Cervical Cancer

June 22, 2016
  • Dave Levitan

A concurrent chemotherapy and radiotherapy regimen with cisplatin and paclitaxel yielded a good response rate and strong long-term survival outcomes in patients with locally advanced or recurrent cervical cancer.

  • READ >>
  • Add new comment

T Cell Diversity in Tumor May Influence Ovarian Cancer Outcomes

June 17, 2016
  • Kunle Odunsi, MD, PhD

In this video Dr. Odunsi discusses a new study that found that higher T-cell diversity in ovarian cancer is associated with poor overall survival.

  • READ >>
  • Add new comment

AXAL Immunotherapy Well-Tolerated in Recurrent Metastatic Cervical Cancer

June 16, 2016
  • Bryant Furlow

A live attenuated bioengineered bacteria-vectored vaccine immunotherapy is well tolerated and appears to be associated with promising overall survival among women with persistent/recurrent metastatic cervical cancer.

  • READ >>
  • Add new comment

IP Carboplatin/IV Paclitaxel Promising in Ovarian, Peritoneal Cancer

June 9, 2016
  • Bryant Furlow

Despite hematologic toxicities and port-related adverse events, IP carboplatin plus IV dose-dense paclitaxel appears to be effective in patients with suboptimally debulked epithelial ovarian or primary peritoneal carcinoma.

  • READ >>
  • Add new comment

Baseline QoL Can Predict Survival in Platinum-Resistant Ovarian Cancer

June 8, 2016
  • Bryant Furlow

Baseline quality of life measures predict early cessation of chemotherapy and overall survival in women with platinum-resistant/refractory, recurrent ovarian cancer.

  • READ >>
  • Add new comment

Extending Platinum-Free Interval Might Reduce Survival in Recurrent Ovarian Cancer

June 8, 2016
  • Bryant Furlow

Extending platinum-free interval with pegylated liposomal doxorubicin, topotecan, or gemcitabine does not improve overall survival among patients with recurrent ovarian cancer.

  • READ >>
  • Add new comment

Pembrolizumab Promising in PD-L1–Positive Squamous Cervical Cancer

June 8, 2016
  • Bryant Furlow

Pembrolizumab is well-tolerated and shows promising antitumor activity and early survival rates among patients with PD-L1–positive cervical squamous cell cancer, according to preliminary results of the KEYNOTE-028 trial.

  • READ >>
  • Add new comment

Metformin Improves Benefit of Everolimus Plus Letrozole in Endometrial Cancer

June 8, 2016
  • Bryant Furlow

Adding metformin to a combination of everolimus plus letrozole for women with advanced or recurrent endometrioid endometrial cancer might offer clinical benefits.

  • READ >>
  • Add new comment

Hormone Maintenance Ups Survival in Low-Grade Serous Carcinoma of Ovary, Peritoneum

June 7, 2016
  • Bryant Furlow

Hormone maintenance therapy is associated with better survival than post-treatment surveillance for women with low-grade serous carcinoma of the ovary or peritoneum.

  • READ >>
  • Add new comment

Pages

  • 1
  • 2
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Breast Cancer
  • Acute Myeloid Leukemia
  • HER2-Positive Breast Cancer
  • Videos Breast Cancer
  • Follicular Lymphoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

ONCOLOGY Vol 33 No 11
Nov 21, 2019 Vol 33 No 11
Subscribe
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".